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Objectives: We conducted a study to provide information on the importance of bacterial pathogens causing child- 
hood meningitis in Bulgaria. 
Methods: A 5-year population-based retrospective survey for bacterial meningitis in children <5 years of age was 
performed at all hospitals in the six largest regions of Bulgaria. 
Results: There were 297 cases of meningitis reported, of which 211 (71.00/ ) 0 were classified as bacterial in origin. The 
most common causes were Neisseria meningitidis (49 cases) and Haemophilus influenzae type b (Hib) (44 cases), 
accounting for 36% and 32% of etiologically confirmed cases. Thirty-one cases (70.5%) of Hib meningitis occurred 
in children <2 years of age, and 26 (59.1%) occurred in children 6-23 months of age. Average annual incidence rates 
of Hib meningitis based on the population of children <5 years of age for each region ranged from 1.3 to 9.8 per 
100 000 (mean 5.9/100 000). 
Conclusion: The estimated incidence rates from this study were similar to those reported from southern European 
and Mediterranean countries. Further studies are planned to provide information on appropriate strategies for pre- 
venting childhood meningitis in Bulgaria. 
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INTRODUCTION 
Bacterial meningitis is one of the most serious pediatric 
infectious diseases, despite the introduction of new anti- 
biotic agents and the availability of intensive care treat- 
ment. Many clinical and etiologic studies performed over 
the past 30 years have demonstrated that Huemophilus 
influenzae type b (Hib), Neisseria meningitidis and 
Streptococcus pneumoniae are the leading causative 
organisms of bacterial meningitis worldwide.lm6 Recently, 
special attention has been paid to Hib, because Hib 
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meningitis and other invasive Hib diseases have been 
virtually eliminated through the widespread use of 
polysaccharide-protein conjugate vaccines in most 
industrialized countries.2,7-11 
In Bulgaria, information on the importance of Hib 
and other bacterial pathogens causing meningitis in 
childhood has been scarce and only derived from 
case series12zr3 and outbreak investigations.14 This report 
presents the findings of a 5-year retrospective survey 
of pediatric meningitis in the six largest regions in 
Bulgaria. 
METHODS 
We conducted a retrospective review of all cases 
of clinical meningitis diagnosed among children 
O-59 months of age between 1 January 1992 and 31 
December 1996 at pediatric and infectious disease depart- 
ments of all hospitals in the six largest regions in Bulgaria. 
The six regions are: Pleven Region, Plovdiv Region, 
Sofia City (the capital of the country), Sofia Region, 
Stara Zagora Region, and Varna Region. Altogether, 
Bulgaria is divided into 28 regions, and the 1996 national 
census showed a total population of 8.3 million.15 For 
the six regions included in the study, there was a total 
1996 population of 3.3 million persons, of whom 149 431 
were children younger than 5 years of age. 
For each hospital, medical charts were examined for 
any children O-59 months of age with an admission 
diagnosis or a discharge diagnosis of meningitis. A 
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standard protocol was used to collect data concerning 
demographic characteristics and clinical history for each 
patient. We also examined all laboratory reports, and 
recorded the identity of the etiologic organism, if known, 
for all cases of bacterial meningitis. 
Patients were classified according to case definitions 
provided in a protocol developed by the World Health 
Organization (WHO).16 A suspected case of meningitis 
was defined as a child <5 years of age presenting with 
clinical symptoms of meningitis, e.g. fever, headache, stiff 
neck, bulging fontanelle, or mental status change. A 
probable case of bacterial meningitis was defined as a 
suspected case with turbid cerebrospinal fluid (CSF), 
or CSF with elevated protein (>lOO mg/dL), decreased 
glucose (~40 mg/dL), or leukocytosis (> 100 white blood 
cells/mm3) with >80% neutrophils. A confirmed case of 
bacterial meningitis was defined as a probable case with 
identification of an organism in the CSF by culture or 
latex agglutination test. 
RESULTS 
During the 5-year period (1 January 1992 to 31 
December 1996), there were 297 cases of clinical menin- 
gitis among children O-59 months of age at hospitals 
in the six regions. Based on laboratory investigations 
of CSF, 211 (71%) cases were classified as probable 
bacterial meningitis, and 86 (29%) were classified as 
probable viral meningitis. Based on culture reports, an 
etiologic agent was identified in 137 (64.9%) of the 211 
patients with bacterial meningitis, while no specific 
organism was detected in the remaining 35.1% (Table 
1). 
N. meningitidis and Hib were the most common 
etiologic agents, accounting for 49 cases (23.2%) and 44 
cases (20.9%), respectively. Twenty-one cases (10.0%) 
were due to S. pneumoniae. When only etiologically 
confirmed cases of bacterial meningitis are included, the 
proportions rise to 35.8% N. meningitidis, 32.1% Hib, 
and 15.3% S. pneumoniae (Figure 1). 
Figure 1. Proportions due to different causative organisms of 
etiologically confirmed cases of bacterial meningitis in children 
O-59 months of age in six regions of Bulgaria, 1992-96. 
Of the six regions, Sofia City was the only one where 
Hib ranked first as a causative agent, with 24 (48.0%) 
cases of meningitis due to Hib versus 12 (24.0%) due to 
N. meningitis (Table 1). 
Thirty-one (70.5%) of the patients with Hib 
meningitis were children younger than 2 years of age, 
and most of them (26 cases, 59.1%) were 6-23 months 
of age (Table 2). The age distribution of cases due to 
iY meningitis was similar. In contrast, the age distribution 
was more uniform for patients with S. pneumoniae 
meningitis. 
Over the 5-year period 1992-96, the average annual 
incidence rates for children O-59 months of age were 
6.6/100 000 for N. meningitis, 5.9/100 000 for Hib, and 
2.8/100 000 for S. pneumoniae. By region, the average 
annual Hib incidence among children O-59 months of 
age ranged from 1.3/100 000 in Pleven to 9.8/100 000 in 
Sofia City. The average annual incidence rate of Hib 
meningitis was higher during the last 2 years of the study 
Table 1. Meningitis in children O-59 months of age in six regions of Bulgaria, 1992-96 
Sofia City Sofia Region Plovdiv Varna P/even Stara Zagora Total 
Organism No. % No. % No. % No. % No. % No. % No. % 
N. meningitidk 
H. influenzae 
type b 
5. pneumoniae 
Othera 
None identified 
Bacterial 
Viral 
Total 
12 24.0 7 28.0 IO 20.8 7 20.6 6 28.6 7 21.2 49 23.2 
24 48.0 2 8.0 9 18.8 2 5.9 1 4.8 6 18.2 44 20.9 
1 2.0 4 16.0 7 14.6 3 8.8 1 4.8 5 15.2 21 10.0 
4 8.0 1 4.0 6 12.5 5 14.7 2 9.5 5 15.2 23 10.9 
9 18.0 11 44.0 16 33.3 17 50.0 11 52.4 10 30.3 74 35.1 
50 100.0 25 100.0 48 100.0 34 100.0 21 100.0 33 100.0 211 100.0 
(71.0%) 
12 17 17 7 20 13 CEO%, 
62 42 65 41 41 46 297 
(100.0%) 
a Including Streptococcus group A, B; Staphylococcus; Candida albicans; Mycobacterium tuberculosis; Pseudomonas aeruginosa, Proteus mirabilis, etc. 
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Table 2. Bacterial meningitis by etiologic agent and age group in six regions of Bulgaria, 1992-96 
Age group (months) 
Cases by agent o-5 6-23 24-59 Total 
N. meningitidis n 4 29 16 49 
% 8.16 59.18 32.65 100.0 
H. influenzae type b n 5 26 13 44 
% 11.36 59.09 29.55 100.0 
5. pneumoniae n 8 8 5 21 
% 38.10 38.10 23.81 100.0 
Other n 14 5 4 23 
% 60.87 21.74 17.39 100.0 
Unidentified n 33 20 21 74 
% 44.59 27.03 28.38 100.0 
Total n 64 88 59 211 
% 30.33 41.72 27.96 100.0 
Table 3. Proportion and average annual incidence rate of Hib meningitis per 100 000 children O-59 months of age in five regions of 
Bulgaria compared with Sofia City Region during 1992-94 and 1995-96 
No. cases 
bacterial 
Years meningitis 
1992-94 94 
1995-96 117 
Five regions 
Hib meningitis 
No. % 
11 11.7 
33 28.2 
Incidence rate 
2.4 
11.0 
No. cases 
bacterial 
meningitis 
24 
26 
Sofia City 
Hib meningitis 
No. % 
6 25.0 
18 69.2 
Incidence rate 
4.1 
18.4 
(1995-96) than during the first 3 years of the study 
(1992-94). During the 2-year period 1995-96, the rate in 
Sofia City (18.4/100 000 children O-59 months of age) 
was substantially higher than that in the other five regions 
(ll.O/lOO 000 children O-59 months of age) (Table 3). 
The average age-specific incidences of Hib meningitis 
were 6.6, 11.5 and 2.8 per 100 000 population aged 
O-5 months, 6-23 months and 24-59 months, respectively. 
For the most affected age group of children <2 years of 
age in Sofia city during the years 1995-96, Hib incidence 
rate peaked at 37.61100 000 population. 
DISCUSSION 
This retrospective survey was part of a WHO-funded 
population-based surveillance study of Hib meningitis in 
Bulgaria, aimed at assessing the local burden of Hib 
meningitis. The survey was planned to provide baseline 
information on the crude rates of bacterial and viral 
meningitis in children <5 years of age and on the signi- 
ficance of different organisms causing bacterial meningitis 
in the same age group. 
Results indicate that, during the 5-year study 
period, childhood meningitis was primarily bacterial in 
origin, and the causative bacterial agent was successfully 
identified in nearly two-thirds of the cases. N. meningitis 
and Hib were determined to be the leading causes of 
bacterial meningitis in Bulgarian children O-59 months 
of age, accounting for 36% and 32% of bacteriologically 
confirmed cases. The peak incidence of Hib disease 
occurred in children aged 6-23 months. These findings 
are consistent with the results of studies performed 
during the 1970s and 1980s in industrialized countries to 
characterize the baseline epidemiology of Hib disease in 
the pre-vaccine era.lm6 
However, the incidence of Hib meningitis estimated 
in our study is low compared to reports from northern 
and central European countries, where it was found to 
range from 22 to 43 per 100 000 before the widespread 
use of Hib vaccines.17-20 The incidence of Hib meningitis 
in Bulgaria is similar to the rates of 4-18 per 100 000 
reported from several southern European and 
Mediterranean countries.21-25 In Japan, the estimated 
incidence rates in a retrospective study ranged by 
region from 3.4 to 9.9 per 100 000 children O-4 years of 
age, with a mean of 4.7/100 000; the results from Japan 
appear to be nearly identical to our findings.26 
There are several possible reasons for the relatively 
low incidence of Hib meningitis found in this study. 
First, Hib may have been under-detected because of 
inadequate techniques for isolation and identification in 
the period covered by this retrospective study. Our study 
indicates substantial region-to-region variation in the 
proportion of Hib meningitis, with regions most success- 
ful in culturing a bacterial isolate showing the highest 
proportion of Hib meningitis (Table 1). 
Prescribing antibiotics before obtaining a CSF 
specimen is known to interfere with the recovery of 
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causative agents by culture. Since it is common practice 
to prescribe antibiotics for febrile infants and young 
children in Bulgaria, this may have also contributed to 
lower incidence rates of Hib meningitis in this study. 
The past decade witnessed the introduction of Hib 
conjugate vaccine into routine childhood immuniza- 
tion.2ss-11 In the developed countries, Hib disease has 
been virtually eliminated in a few years since the intro- 
duction of the vaccine. Lessons learnt in the USA, 
Canada and Europe have clearly demonstrated that it 
would now be possible to prevent >90% of invasive Hib 
infections by routine immunization with the vaccine 
in early infancy. As only 8% of Hib meningitis cases 
in Bulgaria were found to occur before the age of 6 
months, the majority of these severe, life-threatening 
conditions would be prevented by vaccination. 
In conclusion, despite the weaknesses and limitations 
of this retrospective study, it is the first to demonstrate 
that Hib is one of the leading causes of childhood 
bacterial meningitis in Bulgaria, and that Hib is at least as 
important for the country as the endemic N. meningitis. 
Data from this study have challenged the notion that Hib 
is not a major issue for the country. This has drawn the 
attention of medical professionals in Bulgaria to the 
need for further prospective assessment of the burden of 
Hib meningitis in Bulgaria as the next step towards the 
development of appropriate preventive strategies. 
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